Works matching IS 17762596 AND DT 2016 AND VI 11 AND IP 4
Results: 13
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ramucirumab Clinical Development: an Emerging Role in Gastrointestinal Tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Severe Hyponatremia and Immune Nephritis Following an Initial Infusion of Nivolumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?
- Published in:
- 2016
- By:
- Publication type:
- Letter
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report.
- Published in:
- 2016
- By:
- Publication type:
- journal article